U.S. markets open in 5 hours 33 minutes
  • S&P Futures

    4,211.50
    -2.25 (-0.05%)
     
  • Dow Futures

    33,765.00
    +4.00 (+0.01%)
     
  • Nasdaq Futures

    14,093.50
    -36.50 (-0.26%)
     
  • Russell 2000 Futures

    2,279.40
    -1.50 (-0.07%)
     
  • Crude Oil

    73.34
    -0.32 (-0.43%)
     
  • Gold

    1,779.50
    -3.40 (-0.19%)
     
  • Silver

    25.91
    -0.11 (-0.44%)
     
  • EUR/USD

    1.1905
    -0.0020 (-0.17%)
     
  • 10-Yr Bond

    1.4840
    0.0000 (0.00%)
     
  • Vix

    17.90
    -2.80 (-13.53%)
     
  • GBP/USD

    1.3879
    -0.0054 (-0.39%)
     
  • USD/JPY

    110.4630
    +0.1650 (+0.15%)
     
  • BTC-USD

    32,603.90
    -385.31 (-1.17%)
     
  • CMC Crypto 200

    784.49
    -65.86 (-7.74%)
     
  • FTSE 100

    7,079.86
    +17.57 (+0.25%)
     
  • Nikkei 225

    28,884.13
    +873.20 (+3.12%)
     

Earnings Estimates Rising for Eastman Chemical (EMN): Will It Gain?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Eastman Chemical (EMN) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this specialty chemicals maker, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Eastman Chemical, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

Current-Quarter Estimate Revisions

The earnings estimate of $2.27 per share for the current quarter represents a change of +167.06% from the number reported a year ago.

Over the last 30 days, seven estimates have moved higher for Eastman Chemical compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 16.01%.

Current-Year Estimate Revisions

The company is expected to earn $8.66 per share for the full year, which represents a change of +40.81% from the prior-year number.

The revisions trend for the current year also appears quite promising for Eastman Chemical, with eight estimates moving higher over the past month compared to no negative revisions. The consensus estimate has also received a boost over this time frame, increasing 9.38%.

Favorable Zacks Rank

The promising estimate revisions have helped Eastman Chemical earn a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

Investors have been betting on Eastman Chemical because of its solid estimate revisions, as evident from the stock's 14% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Eastman Chemical Company (EMN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research